Purchase Order 75N94022P00642

Award Date 8/14/22
Potential Completion Date 8/17/23
Potential Value $88K
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Exton, PA 19341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, awarded a $16,000 firm-fixed-price purchase order to Imquest Biosciences, Inc., a for-profit preclinical contract research and development organization, for "NIDDK - HIV CYTOPROTECTION ASSAYS 16 COMPOUNDS." The contract has an ultimate completion date of August 31, 2023, and was not set aside for any specific business categories....
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $243,264 firm fixed price purchase order contract to Bioqual, Inc. to provide laboratory analysis services for NIDDK mice studies. The contract, which runs from September 2023 through September 2027 in Potomac, Maryland, was awarded through a solicitation seeking acquisition of such services to support...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $21,486.10 firm fixed-price purchase order contract to Life Chemicals USA, Inc., a self-certified small disadvantaged business, for an "ION CHANNEL SCREENING LIBRARY" with a completion date of July 31, 2023. The contract does not have a set-aside designation. Based on the agency name, this award is likely associated with NIDDK's research activities related to diabetes, digestive, and kidney...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, awarded a $175,089.53 firm-fixed price delivery order to Revolutionary Solutions LLC, a woman-owned small business. The order was placed under Revolutionary Solutions' existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA) and provides administrative support services to...
This is a $116,500.00 firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. The contract is for the provision of various research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and investigational drugs. There is no set-aside...
This firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Valued at $155,100, the contract calls for Frontage Laboratories Inc. to provide services in support of compound 21 testing and in vivo pharmacokinetics studies. Specifically, the prime contractor will scale up production of compound 21 to deliver 10...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $80,095.43 firm fixed price delivery order against the General Services Administration (GSA) Multiple Award Schedule to Shimadzu Scientific Instruments, Inc. for a preparatory high performance liquid chromatography (HPLC) system. Performance will take place in Columbia, Maryland from June 30, 2023...
This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $88,000 firm fixed price purchase order to Frontage Laboratories, Inc., a full-service contract research organization, to provide specialized pharmacokinetic and metabolism research services. The contract supports NIDDK's efforts to advance the testing of a new class of antiviral molecules by conducting blood stability studies, rat and mouse pharmacokinetic studies, and in vitro hepatocyte metabolism studies on two small molecule antivirals. This contract is part of NIDDK's broader work to develop new HIV and other antiviral treatments. The contract was awarded through simplified acquisition procedures without a small business set-aside.

Generated 1/22/25, 9:11 AM